CATHETER STABILIZATION DEVICES MARKET ANALYSIS

Regional Analysis

Catheter Stabilization Devices Market Regional Analysis

North America catheter stabilization devices market is expected to show a significant growth in near future, owing to presence of key players in the region and launch of novel products by them in North America. For instance, in 2013, Tangent Medical (now part of ICU Medical, Inc.) launched its product, NovaCath Integrated IV Catheter System in the U.S. market. NovaCath offers an advanced catheter stabilization technology which meets the Centers for Disease Control and Prevention and Occupational Safety and Health Administration standards for IV catheter stabilization.

Europe catheter stabilization devices market is also expected to show good growth in the near future, owing to high prevalence of cardiovascular diseases which will rise demand for catheter stabilization devices. For instance, according to the data published by European Heart Network and European Society of Cardiology in 2012, cardiovascular diseases (CVD) every year causes over 4 million deaths in Europe and over 1.9 million deaths in the European Union (EU) and such incidents are increasing rapidly.

Asia Pacific catheter stabilization devices market is expected to show a drastic growth over the forecast period, owing to high prevalence of life threatening diseases such as cancer, and Heart diseases. High prevalence of such diseases is expected to increase demand for catheter stabilization device during its treatment. For instance, the data published by American Cancer Society in 2017 shows cancer as the leading cause of death in China, with 4.3 million new cancer cases and 2.8 million cancer deaths occurring each year.